Promotions & Moves

Antengene Appoints CBO

John Chin responsible for global business development and commercialization

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Antengene Corp. has appointed John Chin as chief business officer, responsible for the company’s global business development and commercialization. He reports to Dr. Jay Mei, chairman and chief executive officer of Antengene.  John Chin of Antengene Mr. John Chin has 30 years of pharmaceutical industry experience. Prior to joining Antengene, he was country general manager at Celgene China, leading a cross-functional team to support the development and approval of Celgene assets a...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters